Tenax Therapeutics (TENX) Payables (2016 - 2017)
Historic Payables for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to $579386.0.
- Tenax Therapeutics' Payables fell 5839.46% to $579386.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $579386.0, marking a year-over-year decrease of 5839.46%. This contributed to the annual value of $727599.0 for FY2016, which is N/A changed from last year.
- Per Tenax Therapeutics' latest filing, its Payables stood at $579386.0 for Q3 2017, which was down 5839.46% from $434195.0 recorded in Q2 2017.
- Over the past 5 years, Tenax Therapeutics' Payables peaked at $1.5 million during Q2 2016, and registered a low of $434195.0 during Q2 2017.
- In the last 4 years, Tenax Therapeutics' Payables had a median value of $972483.0 in 2015 and averaged $997078.1.
- As far as peak fluctuations go, Tenax Therapeutics' Payables surged by 7080.84% in 2013, and later crashed by 7146.22% in 2017.
- Quarter analysis of 4 years shows Tenax Therapeutics' Payables stood at $1.0 million in 2013, then fell by 6.01% to $972483.0 in 2015, then decreased by 25.18% to $727599.0 in 2016, then dropped by 20.37% to $579386.0 in 2017.
- Its last three reported values are $579386.0 in Q3 2017, $434195.0 for Q2 2017, and $1.4 million during Q1 2017.